Impact of depressive symptoms on outcomes of a workplace smoking-cessation program;Impacto de la sintomatología depresiva en los resultados de un programa de deshabituación tabáquica en el lugar de trabajo

Adicciones

Volumn 22, Issue 2, 2010, Pages 101-106

  Nieva, Gemma ^a   Bruguera, Eugeni ^a   Valero, Sergi ^a   Casas, Miquel ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

Depression; Nicotine dependence; Smoking; Tobacco; Treatment; Workplace

Indexed keywords

ADULT; ARTICLE; DEPRESSION; HUMAN; MIDDLE AGED; OCCUPATIONAL HEALTH; PSYCHOLOGICAL ASPECT; RETROSPECTIVE STUDY; SMOKING CESSATION;

ADULT; DEPRESSION; HUMANS; MIDDLE AGED; OCCUPATIONAL HEALTH; RETROSPECTIVE STUDIES; SMOKING CESSATION;

EID: 77953447101     PISSN: 02144840     EISSN: None     Source Type: Journal    
DOI: 10.20882/adicciones.198     Document Type: Article

References (34)

1. Encuesta Nacional de Salud 2006. Instituto Nacional de Estadística. Disponible en: http://www.msc.es/estadEstudios/estadisticas/ encuestaNacional/encuesta2006.htm.
2. Moher M, Hey K, Lancaster T. Intervenciones en el lugar de trabajo para el abandono del hábito de fumar (Revisión Cochrane traducida). En: La Biblioteca Cochrane Plus, Número 2. Oxford: Update Software; 2006.
3. National Institute for Health and Clinical Experience. Workplace health promotion: how to help employees to stop smoking. London: National Institute for Health and Clinical Experience; 2007.
4. Kenney BA, Holahan CJ, North RJ, Holahan CK. Depressive symptoms and cigarette smoking in American workers. Am J Health Promot 2006; 20; 179-182
5. Anda RF, Williamson DF, Escobedo LG, Mast EE, Giovino GA, Remington PL. Depression and the dynamics of smoking. A national perspective. JAMA 1990; 264; 1541-1545
6. Covey LS, Tam D. Depressive mood, the single-parent home, and adolescent cigarette smoking. Am J Public Health 1990; 80: 1330-1333
7. Wilhelm K, Wedgwood L, Niven H, Kay-Lambkin F. Smoking cessation and depression: current knowledge and future directions. Drug Alcohol Rev 2006; 25: 97-107.
8. Glassman AH, Stetner F, Walsh BT, Raciman PS, Fleiss JL, Cooper TB, et al. Heavy smokers, smoking cessation, and clonidine: Results of a double-blind, randomised trial. JAMA 1988; 259: 2863-2866
9. Glassman AH, Helzer JE, Covey LS, Cottler LB, Stetner F, Tipp JE, et al. Smoking, smoking cessation and major depression. JAMA 1990; 264: 1546-1549
10. Covey LS, Glassman AH, Stetner F, Becker J. Effect of history of alcoholism or major depression on smoking cessation. Am J Psychiatry 1993; 150: 1546-1547
11. Hall SM, Reus VI, Muñoz RF, Sees KL, Humfleet G, Hartz DT, et al. Nortriptyline and cognitive-behavioral therapy in the treatment of cigarette smoking. Arch Gen Psychiatry 1998; 55: 683-690
12. Covey LS, Glassman AH, Stetner F. Depression and depressive symptoms in smoking cessation. Compr Psychiatry 1990; 31: 350-354 (Pubitemid 20333849)
13. Breslau N, Peterson EL, Schultz LR, Chilcoat HD, Andreski P. Major depression and stages of smoking. Arch Gen Psychiatry 1998;55: 161-166
14. Cox LS, Patten CA, Niaura RS, Decker AP, Rigotti N, Sachs DP, et al. Efficacy of bupropion for relapse prevention in smokers with and without a past history of major depression. J Gen Intern Med 2004; 19: 828-834
15. Ginsberg JP, Klesges RC, Johnson KC, Eck LH, Meyers AW, Winders SA. The relationship between a history of depression and adherence to a multicomponent smoking-cessation program. Addict Behav 1997; 22: 783-787
16. Hall S, Muñoz R, Reus V. Cognitive-behavioral intervention increases abstinence rates for depressive-history smokers. J Consult Clin Psychol 1994; 62: 141-146
17. Hayford KE, Patten CA, Rummans TA, Schroeder DR, Offord KP, Croghan IT, et al. Efficacy of bupropion for smoking cessation in smokers with a former history of major depression or alcoholism. Br J Psychiatry 1999; 174: 173-178
18. Hitsman B, Borrelli B, McChargue DE, Spring B, Niaura R. History of depression and smoking cessation outcome: a meta-analysis. J Consult Clin Psychol 2003; 71: 657-663
19. Kinnunen T, Doherty K, Militello FS, Garvey AJ. Depression and smoking cessation: characteristics of depressed smokers and effects on nicotine replacement. J Consult Clin Psychol 1996; 64:791-798
20. Hughes JR, Stead LF, Lancaster T. Antidepressants for smoking cessation. In: Cochrane Database of Systematic Reviews, Issue 4. Oxford: Update Software; 2006.
21. Fiore MC, Jaén CR, Baker TB, Bailey WC, Benowitz NL, Curry SJ, et al. Treating Tobacco Use and Dependence: 2008 Update. Clinical practice guideline. Rockville: U.S. Department of Health and Human Services, Public Health Service; 2008.
22. Conde V, Useros E. Adaptación castellana de la escala de evaluación conductual para la depresión de Beck. Rev Psiquiatr Psicol Med Eur Am Lat 1975; 12: 217-236
23. Heatherton TF, Kozowski LT, Frecker RC, Fagerström KO. The Fagerström test for nicotine dependence: a revision of the Fagerström Tolerance Questionnaire. Brit J Addict 1991; 86:1119-1127
24. Cummings SR, Richard RJ. Optimum cutoff points for biochemical validation of smoking status. Am J Public Health 1988; 78, 574-575
25. Hughes JR, Keely JP, Niara RS, Ossip-Klein DJ, Richmond RL, Swan Ge. Measures of abstinence in clinical trials: issues and recommendations. Nicotine Tob Res 2003; 5:13-25.
26. Michalak EE, Murria G, Wilkinson C, Dowrick C, Lasa L, Lehtinen V, et al. Estimating depression prevalence from the Beck Depression Inventory: is season of administration a moderator? Psychiatry Res 2004;129: 99-106.
27. Wetter DW, McClure JB, de Moor C, Cofta-Gunn L, Cummings S, Cinciripini PM, et al. Concomitant use of cigarettes and smokeless tobacco: prevalence, correlates, and predictors of tobacco cessation. Prev Med 2002; 34: 638-648
28. Razavi D, Vandecasteele H, Primo C, Bodo M, Debrier F, Verbist H, et al. Maintaining abstinence from cigarette smoking: effectiveness of group counselling and factors predicting outcome. Eur J Cancer 1999; 35: 1238-1247
29. Lang T, Nicaud V, Slama K, Hirch A, Imbernon E, Goldberg M, et al. Smoking cessation at the workplace. Results of a randomised controlled intervention study. J Epidemiol Community Health 2000; 54: 349-354
30. Smedslund G, Fisher KJ, Boles SM, Lichtenstein E. The effectiveness of workplace smoking cessation programmes: a meta-analysis of recent studies. Tob Control 2004;13:197-204.
31. Society for Research on Nicotine and Tobacco Subcommittee on Biochemical Verification. Biochemical verification of tobacco use and cessation. Nicotine Tob Res 2002; 4, 149-159
32. Brown RA, Kahler CW, Niaura R, Abrams DB, Sales SD, Ramsey SE, et al. Cognitive-behavioral treatment for depression in smoking cessation. J Consult Clin Psychol 2001; 69: 471-480
33. Hass AL, Muñoz RF, Humfleet GL, Reus V, Hall SM. Influences of mood, depression history, and treatment modality on outcomes in smoking cessation. J Consult Clin Psychol 2004; 72: 563-570
34. Brown RA, Niaura R, Lloyd-Richardson EE, Strong DR, Kahler CW, Abrantes AM, et al. Bupropion and cognitive-behavioral treatment for depression in smoking cessation. Nicotine Tob Res 2007; 9; 721-730 (Pubitemid 47009227)